| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/13/2011 | CN102010360A Benzo cyclic chiral diamine |
| 04/13/2011 | CN101461804B (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 04/13/2011 | CN101381368B Ethylenediamine schiff base type sweat fingerprint fluorescent reagent, synthesis and use thereof |
| 04/12/2011 | US7923576 Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof |
| 04/12/2011 | US7923560 Delivery of immune response modifier compounds |
| 04/12/2011 | US7923559 7-(3-pyridyl)-1,7-diazaspiro[4.4]nonane; mania, anxiety, dyslexia, schizophrenia, depression, obsessive-compulsive disorders, Tourette's syndrome |
| 04/12/2011 | US7923457 Quinoline derivatives |
| 04/12/2011 | US7923450 Modulators for amyloid beta |
| 04/12/2011 | CA2475619C Piperidine derivatives |
| 04/12/2011 | CA2426461C Nitrogen-containing aromatic derivatives |
| 04/09/2011 | CA2716914A1 Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt |
| 04/08/2011 | CA2786834A1 1-(5-tert-butyl-2-phenyl-2h-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy |
| 04/07/2011 | WO2011041287A1 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors |
| 04/07/2011 | WO2011039670A1 Novel forms of (2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-3,4-dihydro-1h-pyrido[4,3-b] indole) |
| 04/07/2011 | WO2011038579A1 Compounds and compositions as protein kinase inhibitors |
| 04/07/2011 | WO2011015522A3 Process for the manufacture of pharmaceutically active compounds |
| 04/07/2011 | WO2011000945A9 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns |
| 04/07/2011 | WO2010138588A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/07/2011 | WO2010091104A8 Glucosylceramide synthase inhibitors |
| 04/07/2011 | US20110082294 Novel bicyclic compounds |
| 04/07/2011 | US20110082169 Stable SNS-595 Compositions and Methods of Preparation |
| 04/07/2011 | US20110082144 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 04/07/2011 | US20110082140 6-(pyrrolopyridinyl) pyrimidin-2-ylamine derivatives and the use thereof for the treatment of cancer and aids. |
| 04/07/2011 | US20110082138 Imidazopyridin-2-one derivatives |
| 04/07/2011 | US20110082136 Inhibitors of janus kinases |
| 04/07/2011 | US20110082135 Inhibitors of akt activity |
| 04/07/2011 | US20110082132 [4-(1-amino-ehtyl) - cyclohexyl] -methyl-amine and [6-(1-amino-ehtyl) -tetrahydro-pyran-3-yl] -methyl-amine derivatives as antibacterials |
| 04/07/2011 | US20110082130 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 04/07/2011 | US20110081365 Compounds and compositions as tlr activity modulators |
| 04/07/2011 | US20110081297 Novel Substituted Pyrazoles, 1,2,4-Oxadiazoles, and 1,3,4-Oxadiazoles |
| 04/07/2011 | US20110079773 Selectively Functionalized Rylene Imides and Diimides |
| 04/07/2011 | US20110079733 Fluorescent, heterocyclically fused perylenes |
| 04/07/2011 | CA2775587A1 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors |
| 04/06/2011 | EP2305682A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 04/06/2011 | EP2305679A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 04/06/2011 | EP2305678A1 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-ht6 receptors, methods for the production and use thereof |
| 04/06/2011 | EP2305677A1 Alkyne-aryl-naphthyridin-4(1h)-one derivatives as type IV phosphodiesterase inhibitor |
| 04/06/2011 | EP2305664A1 Anabaseine derivatives useful in the treatment of neurodegeneratives diseases |
| 04/06/2011 | EP2305257A1 Amonafide salts and compositions comprising same |
| 04/06/2011 | EP2303882A2 Azacarboline derivatives, preparation method thereof and therapeutic use of same |
| 04/06/2011 | EP2303881A2 Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases |
| 04/06/2011 | EP2303880A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/06/2011 | EP2303879A1 7-azaindole derivatives |
| 04/06/2011 | EP2303878A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 04/06/2011 | EP2303877A1 Process to prepare paliperidone and intermediates thereof |
| 04/06/2011 | EP2303876A1 Diketo azolopiperidines and azolopiperazines as anti-hiv agents |
| 04/06/2011 | EP2303875A2 Compositions with and process for methylmorpholin-subsituted pyrido[2,3-d]pyrimidines |
| 04/06/2011 | EP2303862A2 Wnt protein signalling inhibitors |
| 04/06/2011 | EP2046787B1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 04/06/2011 | EP1934174B1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 04/06/2011 | EP1519939B9 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof |
| 04/06/2011 | CN1812980B Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 04/06/2011 | CN102007637A Novel photosensitizer and photovoltaic element |
| 04/06/2011 | CN102007126A Compounds and compositions as modulators of gpr119 activity |
| 04/06/2011 | CN102007125A Fused heterocyclic derivatives and methods of use |
| 04/06/2011 | CN102007108A Inhibitors of the chemokine receptor cxcr3 |
| 04/06/2011 | CN102006777A Herbicidal coumpounds |
| 04/06/2011 | CN102002042A Method for extracting voacangine from Africa voacanga seeds |
| 04/06/2011 | CN102002041A Phenanthroindolizidine alkaloid derivates and salt thereof as well as application of anti-cancer activity of phenanthroindolizidine alkaloid derivates and salt thereof |
| 04/06/2011 | CN102002040A Synthesis method of triazol pyridine ring compound |
| 04/06/2011 | CN102001985A Fullerene multi-nitrogen heterocyclic water-soluble derivatives as well as preparation method and application thereof |
| 04/06/2011 | CN101486710B Method for synthesizing 3-halogenated indolizine compound |
| 04/05/2011 | US7919623 Naphthyridine derivatives having inhibitory activity against HIV integrase |
| 04/05/2011 | US7919528 Antibiotic; bactericides |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919500 Bis-carbazole DNA intercalating agents for antitumor therapy |
| 04/05/2011 | CA2569850C 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido [2,3-d] pyrimidine derivatives and related compounds for the treatment of cancer |
| 04/05/2011 | CA2537127C Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
| 04/05/2011 | CA2515730C Pyrrolidinohydrochinazolines |
| 04/05/2011 | CA2475434C Aromatic amino acid derivatives and medicinal compositions |
| 04/05/2011 | CA2475432C 2,4,6-triamino-1,3,5-triazine derivative |
| 04/05/2011 | CA2467269C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 03/31/2011 | WO2011038097A2 Indolizine inhibitors of 5-lipoxygenase |
| 03/31/2011 | WO2011038086A2 Indolizine inhibitors of 5-lipoxygenase |
| 03/31/2011 | WO2011036889A1 Heterocyclic compound |
| 03/31/2011 | WO2011036885A1 Heterocyclic compound |
| 03/31/2011 | WO2011036651A1 Pyrazoline dione derivatives as nadph oxidase inhibitors |
| 03/31/2011 | WO2011036461A1 Fused imidazo [3, 2 - d] pyrazines as pi3 kinase inhibitors |
| 03/31/2011 | WO2011036127A1 Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10a inhibitors |
| 03/31/2011 | WO2011035855A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases |
| 03/31/2011 | WO2011035518A1 Pyrimidine derivatives and analogs, preparation method and use thereof |
| 03/31/2011 | WO2011035434A1 Gallium complex anti microbial compounds, compositions, uses and methods |
| 03/31/2011 | WO2011035417A1 Hsp-90 binding compounds, compositions thereof, and their use fn the treatment of autoimmune and inflammatory diseases |
| 03/31/2011 | WO2011035416A1 Hsp90 modulating compounds, compositions, methods and uses |
| 03/31/2011 | WO2010151740A3 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases |
| 03/31/2011 | US20110077404 Process for preparing enantiomerically pure indolopyridines |
| 03/31/2011 | US20110077268 Kinase inhibitors and methods of use |
| 03/31/2011 | US20110077267 Triazolopyridine compound, and action thereof as prolyl hydroxylase inhibitor or erythropoietin production-inducing agent |
| 03/31/2011 | US20110077256 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 03/31/2011 | US20110077248 Imidazopyridine and related analogs as sirtuin modulators |
| 03/31/2011 | US20110077245 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 03/31/2011 | US20110077243 Triazolopyridine Compounds Useful As Kinase Inhibitors |
| 03/31/2011 | US20110077236 New carboxylic acid amides, the preparation thereof and their use as medicaments |
| 03/31/2011 | US20110077235 Apoptosis signal-regulating kinase 1 inhibitors |
| 03/31/2011 | US20110077154 Substituted pyridin-4-yl-methyl sulfonamides as fungicides |
| 03/31/2011 | US20110076230 Novel Substituted Indoles |
| 03/31/2011 | US20110076214 Reversible Room-Temperature Ionic Liquids |
| 03/31/2011 | CA2775475A1 Pyridinylimidazolone derivatives for inhibition of pi3 kinases |
| 03/31/2011 | CA2775328A1 Pyrido[4,3-b]indoles and methods of use |
| 03/31/2011 | CA2775216A1 Bridged heterocyclic compounds and methods of use |